These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis and Selective Anticancer Activity Evaluation of 2-phenylacrylonitrile Derivatives as Tubulin Inhibitors. Jin YZ, Xin YB, Li Y, Chen XY, Man DA, Tian YS. Curr Med Chem; 2024 May 15; 31(15):2090-2106. PubMed ID: 38384112 [Abstract] [Full Text] [Related]
26. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Abdel-Aziz M, Metwally KA, Gamal-Eldeen AM, Aly OM. Anticancer Agents Med Chem; 2015 May 15; 16(2):269-77. PubMed ID: 26343141 [Abstract] [Full Text] [Related]
28. Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors. Zhang S, Mo M, Lv M, Xia W, Liu K, Yu G, Yu J, Xu G, Zeng X, Cheng S, Xu B, Luo H, Meng X. Future Med Chem; 2023 Nov 15; 15(21):1967-1986. PubMed ID: 37937524 [Abstract] [Full Text] [Related]
29. Design, Synthesis, in silico and in vitro Evaluation of New Combretastatin A-4 Analogs as Antimitotic Antitumor Agents. Hussein SAA, Kubba A, Balakit AA, Tahtamouni LH, Abbas AH. Med Chem; 2023 Nov 15; 19(10):1018-1036. PubMed ID: 37259214 [Abstract] [Full Text] [Related]
30. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors. Yang F, He CP, Diao PC, Hong KH, Rao JJ, Zhao PL. Bioorg Med Chem Lett; 2019 Jan 01; 29(1):22-27. PubMed ID: 30448234 [Abstract] [Full Text] [Related]
31. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]
35. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site. Yan XY, Leng JF, Chen TT, Zhao YJ, Kong LY, Yin Y. Eur J Med Chem; 2022 Jul 05; 237():114372. PubMed ID: 35447432 [Abstract] [Full Text] [Related]
36. Synthesis, Molecular Docking, and Biological Evaluation of 2,3-Diphenylquinoxaline Derivatives as a Tubulin's Colchicine Binding Site Inhibitor Based on Primary Virtual Screening. Rezaei Z, Asadi M, Montazer MN, Rezaeiamiri E, Bahadorikhalili S, Amini M, Amanlou M. Anticancer Agents Med Chem; 2022 Jul 05; 22(10):2011-2025. PubMed ID: 34702157 [Abstract] [Full Text] [Related]
37. Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities. Yang F, Yu LZ, Diao PC, Jian XE, Zhou MF, Jiang CS, You WW, Ma WF, Zhao PL. Bioorg Chem; 2019 Nov 05; 92():103260. PubMed ID: 31525523 [Abstract] [Full Text] [Related]
39. Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents. Carta D, Bortolozzi R, Sturlese M, Salmaso V, Hamel E, Basso G, Calderan L, Quintieri L, Moro S, Viola G, Ferlin MG. Eur J Med Chem; 2017 Feb 15; 127():643-660. PubMed ID: 27823884 [Abstract] [Full Text] [Related]
40. Effect of Hybrid Compounds of Stilbene and Pentadienone on Inhibition of Tubulin Polymerization. Park J, Koh D, Lee YH, Lim Y, Shin SY. Anticancer Agents Med Chem; 2023 Feb 15; 23(10):1156-1163. PubMed ID: 36797615 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]